Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Diffuse large B-cell lymphoma can be classified by gene expression profiling into germinal center and activated B-cell subtypes with different prognoses after rituximab-CHOP. The importance of previously recognized prognostic markers, such as Bcl-2 protein expression and BCL2 gene abnormalities, has...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Visco, Carlo, Tzankov, Alexander, Xu-Monette, Zijun Y., Miranda, Roberto N., Tai, Yu Chuan, Li, Yan, Liu, Wei-min, d'Amore, Emanuele S. G., Li, Yong, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Wang, Huan-You, Dunphy, Cherie H., His, Eric D., Zhao, X. Frank, Choi, William WL., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Ai, Weiyun, O'Neill, Stacey, Ponzoni, Maurilio, Ferreri, Andres JM., Kahl, Brad S., Winter, Jane N., Go, Ronald S., Dirnhofer, Stephan, Piris, Miguel A., Møller, Michael B., Wu, Lin, Medeiros, L. Jeffrey, Young, Ken H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2013
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561433/
https://ncbi.nlm.nih.gov/pubmed/22929980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066209
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller